NeuroSense Therapeutics Ltd. - NRSN Narxning prognoz qilingan daromadga nisbati
NeuroSense Therapeutics (NRSN) — RNA regulyatsiyasi orqali neyrodegenerativ patologiyalar uchun kompleks terapiyalarni ishlab chiqayotgan biofarmatsevtika innovatori hisoblanadi. Oldingi P/S baholash koeffitsiyenti bozor kutganlarining dinamikasini aniq namoyish etadi, bunda ushbu parametrning joriy darajasini belgilaydi. Potentsial daromadlar Parkinson kasalligi va ALS davolashga asoslangan, biroq, mablag'larning tez sarflanishi va klinik sinovlarga bog'liqlik sezilarli moliyaviy xatarlarni yuzaga keltirmoqda.
neurosense-tx.com (NRSN) kompaniyasining tahliliy kesimlari
- bozor narxi va tahlilchilarning maqsadli narxlari:
- emitentning bozor qiymati haqida ma'lumotlar:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Umumiy qarzning xususiy kapitalga nisbati NeuroSense Therapeutics|NRSN - Uzoq muddatli kreditlarning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati NeuroSense Therapeutics Ltd.|NRSN - Jamlangan qarz majburiyatlari|Balans kapitallashuviga qarzlar NeuroSense Therapeutics|NRSN - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli qarzi NeuroSense Therapeutics|Tezkor likvidlik koeffitsiyenti neurosense-tx.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
NRSN - Sof foyda|Kutilayotgan foyda NeuroSense Therapeutics|NRSN - Kapitalizatsiyaning sof foydaga nisbati|Forvard P/E multiplikatori NeuroSense Therapeutics Ltd.|NRSN - O‘sish sur’atiga tuzatilgan narx-foyda|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti NeuroSense Therapeutics|NRSN - EBITDA operatsion foydasi|So'nggi 12 oy davomida bir aksiya uchun sof foyda NeuroSense Therapeutics|NRSN - So'nggi to'rtta chorak uchun bir aksiya uchun foyda|Choraklik EPS foyda o'sishi neurosense-tx.com|NRSN - Bu yil bir aksiya uchun sof foydaning kutilayotgan o'sishi|Keyingi yil uchun foyda o'sishi prognozi NeuroSense Therapeutics
- tushum va sotuvlar tafsilotlari:
Kompaniyaning jamlanma tahlili:NeuroSense Therapeutics, Ltd. NRSN
Forward P/S ko'rsatkichi prognoz qilingan daromadga nisbatan bozor kapitalizatsiyasini o'lchaydi, bu esa investorga aktivning haddan tashqari qimmat baholanganlik darajasini aniqlash va kutishlar o'zgarganda korreksiya potentsialini baholash imkonini beradi. Taxminiy forward P/S ko'rsatkichini tahlil qilish orqali spekulyativ vasvasani filtrlash mumkin, bu esa NeuroSense Therapeutics (NRSN) uchun juda muhimdir, chunki uning joriy bahosi hozirgi foydaga emas, balki ALS dori vositalari uchun klinik sinovlarning yuqori xavfli natijalariga asoslangan.
Raqobatchilar tahlili
Narxning prognoz qilingan daromadga nisbati Biogen BIIB|NBIX: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|RGC - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Axsome Corp AXSM|ACAD: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati xenon-pharma.com (XENE)|Forvard narx/daromad multiplikatori VKTX|SUPN: Sotuvga nisbatan forvard narx|Forvard narx/daromad multiplikatori CPRX (Catalyst Pharmaceuticals Inc)|Narxning kutilayotgan daromadga nisbati DNLI|Forvard P/S multiplikatori HRMY (Harmony Biosciences)|Sotuvga nisbatan forvard narx BHVN|Amylyx Pharmaceuticals, Inc. - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Trevi Therapeutics Inc|Praxis Medicines (PRAX) - Narxning prognoz qilingan daromadga nisbati|Anavex Life Sciences Corp - Sotuvga nisbatan forvard narx|CBLL (CeriBell, Inc.) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Prothena Corporation|Narxning prognoz qilingan daromadga nisbati Alector, Inc. (ALEC)|ANNX: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori OMER (Omeros)|Neurogene Therapeutics (NGNE) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|ACIU: Forvard narx/daromad multiplikatori|VYGR - Forvard P/S multiplikatori|NMRA (Neumora Therapeutics, Inc.) - Forvard narx/daromad multiplikatori|SCLX: Narxning kutilayotgan daromadga nisbati|TVGN (Tevogen Bio Holdings, Inc.) - Forvard P/S multiplikatori|Alpha Cognition Corp (ACOG) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori CGTX|Forvard narx/daromad multiplikatori inhibikase.com IKT|Narxning prognoz qilingan daromadga nisbati Cassava Sciences SAVA|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Assertio Holdings (ASRT)|COYA - Narxning prognoz qilingan daromadga nisbati|VTGN (Vistagen Therapeutics) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|ovidrx.com (OVID) - Narxning prognoz qilingan daromadga nisbati|acumenpharm.com - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati CervoMed|Alterity Therapeutics Ltd (ATHE) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Clene Inc. (CLNN)|pepgen.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Jupiter Neurosciences Inc JUNS|RLMD: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Annovis Bio - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Grace Therapeutics, Inc.|AIFF (Firefly Neuroscience Inc) - Forvard narx/daromad multiplikatori|Klotho Neurosciences (KLTO) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Reviva Pharmaceuticals|MTVA: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati NeurAxis (NRXS)|HSDT - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Passage Bio PASG|NEUP: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Minerva Neurosciences - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati athira.com|ADXN (Addex Therapeutics Ltd) - Forvard narx/daromad multiplikatori|Alzamend Neuro (ALZN) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Cyclerion Therapeutics Inc.|PTIX: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Pasithea Therapeutics (KTTA)|CRGT - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Avenue Therapeutics, Inc. ATXI|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Brainstorm Cell Therapeutics Inc. (BCLI)|Cara Therapeutics, Inc - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Chromocell|eliemtx.com (ELYM) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ITCI|Narxning prognoz qilingan daromadga nisbati Longboard Pharmaceuticals, Inc.|Marinus Pharmaceuticals Inc (MRNS) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori NKGN|NRBO - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Sage Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx SNPX|TRVN: Forvard narx/daromad multiplikatori|Vigil Neuroscience - Narxning kutilayotgan daromadga nisbati|WENA: Forvard P/S multiplikatori|Cerevel Corp - Sotuvga nisbatan forvard narx
